EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Trh suppressed gastric acid output in patients with zollinger ellison syndrome and systemic mastocytosis



Trh suppressed gastric acid output in patients with zollinger ellison syndrome and systemic mastocytosis



American Journal of Medicine 71(6): 957-960



TRH administered i.v. was as potent an inhibitor of gastric acid secretion as a conventional dose of oral cimetidine in 2 patients with Zollinger-Ellison syndrome and 1 patient with systemic mastocytosis.

(PDF 0-2 workdays service: $29.90)

Accession: 006839816

Download citation: RISBibTeXText



Related references

Thyrotropin-releasing hormone suppressed gastric acid output in patients with Zollinger-Ellison syndrome and systemic mastocytosis. American Journal of Medicine 71(6): 957-960, 1981

Parenteral control of gastric acid output in patients with zollinger ellison syndrome zes. Gastroenterology 100(5 PART 2): A79, 1991

Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. American Journal of Gastroenterology 102(12): 2648-2654, 2007

Thyrotropin releasing hormone suppress gastric acid output in patients with zollinger ellison syndrome. Clinical Research 28(4): 724A, 1980

Effect of somatostatin on serum gastrin levels and on gastric acid output in patients with zollinger ellison syndrome. Scandinavian Journal of Gastroenterology Supplement 18(82): 205-206, 1982

Effects of lansoprazole and omeprazole on 24 hour gastric acidity and baseline acid output in nine patients with Zollinger-Ellison syndrome. Gastroenterologie Clinique et Biologique 18(8-9): 695-701, 1994

Does the magnitude of gastric acid output correlate with the extent of hypergastrinemia in patients with zollinger-ellison syndrome ? A prospective study. Gastroenterology 116(4 PART 2): A170-A171, April, 1999

Effects of pantoprazole versus reference PPIs on 24-hour gastric acidity and basal acid output in patients with Zollinger-Ellison Syndrome. Gastroenterology 116(4 PART 2): A252, April, 1999

Systemic mastocytosis and the Zollinger-Ellison syndrome. Schweizerische Rundschau für Medizin Praxis 63(18): 558-559, 1974

Intravenous pantoprazole rapidly and effectively controls acid output in patients with Zollinger-Ellison Syndrome. Gastroenterology 114(4 PART 2): A226, April 15, 1998

Gastric pepsin acid correlation in patients with Zollinger-Ellison syndrome. Nihon Shokakibyo Gakkai Zasshi 80(1): 24-28, 1983

Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. Alimentary Pharmacology & Therapeutics 15(1): 87-103, January, 2001

Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World Journal of Surgery 17(4): 468-480, 1993

Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Digestive Diseases & Sciences. 38(10): 1857-1865, 1993